PMC:7172841 / 980-1106 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T11","span":{"begin":76,"end":87},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma62863"}],"text":"ocilizumab treatment of patients was accompanied by increase in circulating lymphocytes. Thus, the unique pattern of immune dy"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T36","span":{"begin":64,"end":75},"obj":"CL:0000080"},{"id":"T37","span":{"begin":76,"end":87},"obj":"CL:0000542"},{"id":"T38","span":{"begin":117,"end":123},"obj":"UBERON:0002405"},{"id":"T74668","span":{"begin":64,"end":75},"obj":"CL:0000080"},{"id":"T90672","span":{"begin":76,"end":87},"obj":"CL:0000542"},{"id":"T2958","span":{"begin":117,"end":123},"obj":"UBERON:0002405"}],"text":"ocilizumab treatment of patients was accompanied by increase in circulating lymphocytes. Thus, the unique pattern of immune dy"}

{"project":"LitCovid-PubTator","denotations":[{"id":"48","span":{"begin":24,"end":32},"obj":"Species"}],"attributes":[{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ocilizumab treatment of patients was accompanied by increase in circulating lymphocytes. Thus, the unique pattern of immune dy"}